Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Drug, Healthcare and Patient Safety
|
March 6, 2013
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits
Jan Thöne, Gisa Ellrichmann
European Neurology
|
April 26, 2008
Deep brain stimulation improves performance of complex instrumental paradigms
Gisa Ellrichmann, Ali Harati, Thomas Müller
Neurology
|
February 8, 2012
Teaching Video NeuroImages: spinal and bulbar muscular atrophy mimicking essential tremor
Antonios Kerasnoudis, Gisa Ellrichmann, Ralf Gold, et al.
BMJ Case Reports
|
August 20, 2011
Ascending myelitis
Christian Börnke, Gisa Ellrichmann, Peter Mönnings, et al.
Therapeutic Advances in Neurological Disorders
|
July 28, 2022
Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort
Jannis Achenbach, Carsten Saft, Simon Faissner, et al.
BMJ Case Reports
|
July 10, 2014
Osmotic demyelination syndrome
Christian Börnke, Gisa Ellrichmann, Ruth Schneider, et al.
Clinical & Developmental Immunology
|
August 20, 2013
The role of the immune system in Huntington's disease
Gisa Ellrichmann, Christiane Reick, Carsten Saft, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 15, 2017
Recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis with associated ampicillin-induced myoclonic twitches
Anna L Fisse, Katrin Straßburger-Krogias, Ralf Gold, et al.
BMC Neurology
|
June 27, 2024
Incidence of Parkinson's disease in Germany based on prevalence data from 70 million patients of the statutory health insurance
Claudius Wattenbach, Gisa Ellrichmann, Insa Feinkohl, et al.
BMC Medical Education
|
May 13, 2022
Germany-wide evaluation of residency in neurological intensive care medicine
Ann-Kathrin Ernst, Michaela Zupanic, Gisa Ellrichmann, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Drug, Healthcare and Patient Safety
|
March 6, 2013
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits
Jan Thöne, Gisa Ellrichmann
European Neurology
|
April 26, 2008
Deep brain stimulation improves performance of complex instrumental paradigms
Gisa Ellrichmann, Ali Harati, Thomas Müller
Neurology
|
February 8, 2012
Teaching Video NeuroImages: spinal and bulbar muscular atrophy mimicking essential tremor
Antonios Kerasnoudis, Gisa Ellrichmann, Ralf Gold, et al.
BMJ Case Reports
|
August 20, 2011
Ascending myelitis
Christian Börnke, Gisa Ellrichmann, Peter Mönnings, et al.
Therapeutic Advances in Neurological Disorders
|
July 28, 2022
Positive effect of immunomodulatory therapies on disease progression in Huntington's disease? Data from a real-world cohort
Jannis Achenbach, Carsten Saft, Simon Faissner, et al.
BMJ Case Reports
|
July 10, 2014
Osmotic demyelination syndrome
Christian Börnke, Gisa Ellrichmann, Ruth Schneider, et al.
Clinical & Developmental Immunology
|
August 20, 2013
The role of the immune system in Huntington's disease
Gisa Ellrichmann, Christiane Reick, Carsten Saft, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 15, 2017
Recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis with associated ampicillin-induced myoclonic twitches
Anna L Fisse, Katrin Straßburger-Krogias, Ralf Gold, et al.
BMC Neurology
|
June 27, 2024
Incidence of Parkinson's disease in Germany based on prevalence data from 70 million patients of the statutory health insurance
Claudius Wattenbach, Gisa Ellrichmann, Insa Feinkohl, et al.
BMC Medical Education
|
May 13, 2022
Germany-wide evaluation of residency in neurological intensive care medicine
Ann-Kathrin Ernst, Michaela Zupanic, Gisa Ellrichmann, et al.
Page
of 6